Figure 1
Identification of ERBB4 and COL29A1 as specific outliers in ALK-negative ALCL. (A) COPA of T-NHL microarray data revealed ERBB4 and COL29A1 as outlier genes in ALK-negative ALCL. ALK, ERBB4, and COL29A1 expression (normalized expression units) are shown from all profiled samples (data set from Agnelli et al11). Sample classes are indicated according to the color scale. Angioimmunoblastic lymphoma (AILT; 41 samples), ALK-negative ALCL (24 samples), ALK-positive ALCL (30 samples), normal T cells (69 samples), PTCL-NOS (74 samples); adult T-cell leukemia/lymphoma (ATLL; 11 samples), cell lines (4 samples). (B) Hierarchical clustering of transcripts correlated to ERBB4 expression in ALCL samples (ALK-positive, yellow; ALK-negative, blue), as revealed by the average linkage method using Euclidean distance. Each column represents a sample, and each row a gene. The color scale bar represents relative gene expression changes, normalized by the standard deviation. Microarray data analysis was performed as described in Piva et al15. (C) Unbalanced expression of ERBB4 transcripts. Expression of ERBB4 (exons 1-2 and 24-25) was assessed by qRT-PCR in 8 ALCL cases and in the breast cancer cell line T47D, used as a positive control. (D) Distribution of ERBB4 and COL29A1 RNA sequencing reads in a representative ERBB4-positive ALCL case. (E) Electropherograms of 2 ERBB4-truncated transcripts: I20Δ (exon 21 carrying at 5′ a portion of intron 20 (GRCh37:2:212329687:212330078) and I12Δ (exon 13 carrying at 5′ a portion of intron 12 (GRCh37:2:212558507:212558780). Fragments were identified by RLM-RACE in a representative ERBB4-positive ALCL case. Arrows point to the position of intron-exon junctions.

Identification of ERBB4 and COL29A1 as specific outliers in ALK-negative ALCL. (A) COPA of T-NHL microarray data revealed ERBB4 and COL29A1 as outlier genes in ALK-negative ALCL. ALK, ERBB4, and COL29A1 expression (normalized expression units) are shown from all profiled samples (data set from Agnelli et al11 ). Sample classes are indicated according to the color scale. Angioimmunoblastic lymphoma (AILT; 41 samples), ALK-negative ALCL (24 samples), ALK-positive ALCL (30 samples), normal T cells (69 samples), PTCL-NOS (74 samples); adult T-cell leukemia/lymphoma (ATLL; 11 samples), cell lines (4 samples). (B) Hierarchical clustering of transcripts correlated to ERBB4 expression in ALCL samples (ALK-positive, yellow; ALK-negative, blue), as revealed by the average linkage method using Euclidean distance. Each column represents a sample, and each row a gene. The color scale bar represents relative gene expression changes, normalized by the standard deviation. Microarray data analysis was performed as described in Piva et al15 . (C) Unbalanced expression of ERBB4 transcripts. Expression of ERBB4 (exons 1-2 and 24-25) was assessed by qRT-PCR in 8 ALCL cases and in the breast cancer cell line T47D, used as a positive control. (D) Distribution of ERBB4 and COL29A1 RNA sequencing reads in a representative ERBB4-positive ALCL case. (E) Electropherograms of 2 ERBB4-truncated transcripts: I20Δ (exon 21 carrying at 5′ a portion of intron 20 (GRCh37:2:212329687:212330078) and I12Δ (exon 13 carrying at 5′ a portion of intron 12 (GRCh37:2:212558507:212558780). Fragments were identified by RLM-RACE in a representative ERBB4-positive ALCL case. Arrows point to the position of intron-exon junctions.

Close Modal

or Create an Account

Close Modal
Close Modal